Skip navigation

FDA weighs updated kids’ pneumococcal shot

Prevnar 13 didn't meet some effectiveness goals for anti-infection vaccine

Kids and parenting videos
Heavy metal: Are Zhu Zhu toys toxic?
Dec. 7: Concerns that the Go Go Hamster may pose a health risk to children persisted Monday after a consumer safety group raised a red flag about high levels of the metalloid antimony. The CPSC said the toy cleared U.S. safety standards. NBC's Tom Costello reports.

updated 1:54 p.m. ET Nov. 16, 2009

WASHINGTON - The Food and Drug Administration is weighing whether to approve an updated version of Pfizer's best-selling anti-infection vaccine for children, despite company studies that failed to meet certain goals.

The Prevnar 13 vaccine reduces risk of infection by 13 varieties of pneumococcal disease, which causes ear infections, meningitis and pneumonia. The new version of the vaccine protects against six more varieties of the disease.

But FDA reviewers say in online documents that company studies failed to meet effectiveness goals for three types of pneumococcal disease.

Story continues below ↓
advertisement | your ad here

The FDA will ask a panel of outside vaccine experts to weigh in on the results at a meeting Wednesday. The agency is not required to follow the group's advice, though it usually does.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Resource guide